KalGene Pharmaceuticals Inc
Developing Therapy to Cure Alzheimer's
We are developing therapeutics to cure Alzheimer' s. We anticipate to partner with big pharmaceuticals to conduct Phase iii and exit at this stage ( three years). Company received 3 M grant in 2016 to develop the product and may receive additional 3 M in 2017 grant to complete the Phase 1 clinical studies.
Exit might provide 10-20 fold upside for the investors in three years.